Structure

Physi-Chem Properties

Molecular Weight:  402.24
Volume:  434.68
LogP:  3.406
LogD:  3.035
LogS:  -3.967
# Rotatable Bonds:  10
TPSA:  80.67
# H-Bond Aceptor:  5
# H-Bond Donor:  1
# Rings:  2
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.359
Synthetic Accessibility Score:  5.199
Fsp3:  0.625
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.761
MDCK Permeability:  1.813538619899191e-05
Pgp-inhibitor:  0.015
Pgp-substrate:  0.032
Human Intestinal Absorption (HIA):  0.032
20% Bioavailability (F20%):  0.128
30% Bioavailability (F30%):  0.235

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.982
Plasma Protein Binding (PPB):  69.97651672363281%
Volume Distribution (VD):  1.814
Pgp-substrate:  39.960853576660156%

ADMET: Metabolism

CYP1A2-inhibitor:  0.023
CYP1A2-substrate:  0.101
CYP2C19-inhibitor:  0.028
CYP2C19-substrate:  0.289
CYP2C9-inhibitor:  0.031
CYP2C9-substrate:  0.177
CYP2D6-inhibitor:  0.017
CYP2D6-substrate:  0.12
CYP3A4-inhibitor:  0.835
CYP3A4-substrate:  0.355

ADMET: Excretion

Clearance (CL):  7.477
Half-life (T1/2):  0.596

ADMET: Toxicity

hERG Blockers:  0.171
Human Hepatotoxicity (H-HT):  0.604
Drug-inuced Liver Injury (DILI):  0.253
AMES Toxicity:  0.631
Rat Oral Acute Toxicity:  0.844
Maximum Recommended Daily Dose:  0.982
Skin Sensitization:  0.976
Carcinogencity:  0.706
Eye Corrosion:  0.298
Eye Irritation:  0.052
Respiratory Toxicity:  0.975

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC476802

Natural Product ID:  NPC476802
Common Name*:   Caseanigrescen D2
IUPAC Name:   [(2R,4aS,5S,7R,8R,8aS)-4,4a-diformyl-5-hydroxy-7,8-dimethyl-8-(3-methylidenepent-4-enyl)-1,2,5,6,7,8a-hexahydronaphthalen-2-yl] butanoate
Synonyms:   Caseanigrescen D2
Standard InCHIKey:  LJKLFXDBDBCJPX-UYLBCASOSA-N
Standard InCHI:  InChI=1S/C24H34O5/c1-6-8-22(28)29-19-12-18(14-25)24(15-26)20(13-19)23(5,10-9-16(3)7-2)17(4)11-21(24)27/h7,12,14-15,17,19-21,27H,2-3,6,8-11,13H2,1,4-5H3/t17-,19+,20+,21+,23-,24+/m1/s1
SMILES:  CCCC(=O)O[C@@H]1C[C@H]2[C@]([C@@H](C[C@@H]([C@]2(C(=C1)C=O)C=O)O)C)(C)CCC(=C)C=C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   16109796
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0001757] Colensane and clerodane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO31135 Casearia nigrescens Species Salicaceae Eukaryota n.a. leaf n.a. PMID[17315961]
NPO31135 Casearia nigrescens Species Salicaceae Eukaryota n.a. flower n.a. PMID[17315961]
NPO31135 Casearia nigrescens Species Salicaceae Eukaryota leaves and flowers Zahamena region of Madagascar, Toamasina, 3 km northeast of Nosivola (1741'01?S, 4838'28?) 2001-NOV PMID[17315961]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT179 Cell Line A2780 Homo sapiens IC50 = 1500 nM PMID[17315961]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC476802 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC89171
0.9612 High Similarity NPC476801
0.95 High Similarity NPC470297
0.8704 High Similarity NPC277769
0.8679 High Similarity NPC189075
0.8679 High Similarity NPC275539
0.8667 High Similarity NPC1679
0.8667 High Similarity NPC469607
0.8654 High Similarity NPC95585
0.8654 High Similarity NPC282233
0.8641 High Similarity NPC471412
0.8627 High Similarity NPC23364
0.8598 High Similarity NPC474243
0.8585 High Similarity NPC110496
0.8559 High Similarity NPC474518
0.8545 High Similarity NPC238667
0.8544 High Similarity NPC471413
0.8532 High Similarity NPC4573
0.8532 High Similarity NPC90952
0.8515 High Similarity NPC183012
0.8476 Intermediate Similarity NPC95899
0.8476 Intermediate Similarity NPC120321
0.8416 Intermediate Similarity NPC470697
0.8416 Intermediate Similarity NPC250075
0.8396 Intermediate Similarity NPC118911
0.8393 Intermediate Similarity NPC134430
0.8393 Intermediate Similarity NPC476959
0.8381 Intermediate Similarity NPC273005
0.8381 Intermediate Similarity NPC31058
0.8381 Intermediate Similarity NPC469606
0.8381 Intermediate Similarity NPC162973
0.8365 Intermediate Similarity NPC476299
0.8365 Intermediate Similarity NPC474012
0.8365 Intermediate Similarity NPC174314
0.8364 Intermediate Similarity NPC12046
0.8364 Intermediate Similarity NPC194951
0.8364 Intermediate Similarity NPC269530
0.8333 Intermediate Similarity NPC476962
0.8333 Intermediate Similarity NPC476479
0.8319 Intermediate Similarity NPC284707
0.8302 Intermediate Similarity NPC254202
0.8288 Intermediate Similarity NPC25909
0.8288 Intermediate Similarity NPC471204
0.8288 Intermediate Similarity NPC157441
0.8288 Intermediate Similarity NPC469463
0.8288 Intermediate Similarity NPC56448
0.8288 Intermediate Similarity NPC469454
0.8288 Intermediate Similarity NPC469496
0.8286 Intermediate Similarity NPC111292
0.8283 Intermediate Similarity NPC473229
0.8269 Intermediate Similarity NPC316598
0.8269 Intermediate Similarity NPC216478
0.8252 Intermediate Similarity NPC29952
0.8252 Intermediate Similarity NPC202833
0.8246 Intermediate Similarity NPC476960
0.8246 Intermediate Similarity NPC473636
0.8246 Intermediate Similarity NPC77689
0.8241 Intermediate Similarity NPC179380
0.823 Intermediate Similarity NPC469684
0.823 Intermediate Similarity NPC53396
0.823 Intermediate Similarity NPC475809
0.823 Intermediate Similarity NPC98249
0.8224 Intermediate Similarity NPC96268
0.8218 Intermediate Similarity NPC477574
0.8214 Intermediate Similarity NPC470953
0.8208 Intermediate Similarity NPC164551
0.8208 Intermediate Similarity NPC476081
0.8208 Intermediate Similarity NPC137430
0.8198 Intermediate Similarity NPC69291
0.819 Intermediate Similarity NPC47024
0.819 Intermediate Similarity NPC117685
0.819 Intermediate Similarity NPC54705
0.819 Intermediate Similarity NPC306856
0.819 Intermediate Similarity NPC476933
0.8182 Intermediate Similarity NPC478209
0.8182 Intermediate Similarity NPC5103
0.8174 Intermediate Similarity NPC476961
0.8173 Intermediate Similarity NPC474343
0.8165 Intermediate Similarity NPC306265
0.8165 Intermediate Similarity NPC151393
0.8165 Intermediate Similarity NPC322903
0.8158 Intermediate Similarity NPC21326
0.8148 Intermediate Similarity NPC478208
0.8142 Intermediate Similarity NPC469794
0.8142 Intermediate Similarity NPC476963
0.8142 Intermediate Similarity NPC72772
0.8131 Intermediate Similarity NPC8196
0.8131 Intermediate Similarity NPC478057
0.8131 Intermediate Similarity NPC156681
0.8131 Intermediate Similarity NPC159533
0.8131 Intermediate Similarity NPC99266
0.8131 Intermediate Similarity NPC159442
0.8125 Intermediate Similarity NPC159333
0.8125 Intermediate Similarity NPC472926
0.812 Intermediate Similarity NPC55602
0.812 Intermediate Similarity NPC469789
0.812 Intermediate Similarity NPC11895
0.8119 Intermediate Similarity NPC158488
0.8113 Intermediate Similarity NPC224720
0.8113 Intermediate Similarity NPC476240
0.8113 Intermediate Similarity NPC242666
0.8113 Intermediate Similarity NPC476223
0.8113 Intermediate Similarity NPC472637
0.8113 Intermediate Similarity NPC303559
0.8108 Intermediate Similarity NPC179798
0.8108 Intermediate Similarity NPC304180
0.8108 Intermediate Similarity NPC474315
0.8108 Intermediate Similarity NPC188738
0.8095 Intermediate Similarity NPC57079
0.8095 Intermediate Similarity NPC478056
0.8095 Intermediate Similarity NPC108368
0.8095 Intermediate Similarity NPC476807
0.8095 Intermediate Similarity NPC476806
0.8087 Intermediate Similarity NPC473839
0.8087 Intermediate Similarity NPC211093
0.8077 Intermediate Similarity NPC242848
0.8077 Intermediate Similarity NPC134072
0.8077 Intermediate Similarity NPC61369
0.8077 Intermediate Similarity NPC234993
0.8077 Intermediate Similarity NPC469545
0.8077 Intermediate Similarity NPC5532
0.8073 Intermediate Similarity NPC78966
0.8073 Intermediate Similarity NPC143609
0.8073 Intermediate Similarity NPC133422
0.8073 Intermediate Similarity NPC472925
0.8073 Intermediate Similarity NPC284732
0.807 Intermediate Similarity NPC239273
0.807 Intermediate Similarity NPC284068
0.807 Intermediate Similarity NPC472927
0.8058 Intermediate Similarity NPC477130
0.8058 Intermediate Similarity NPC477129
0.8058 Intermediate Similarity NPC57117
0.8058 Intermediate Similarity NPC269729
0.8056 Intermediate Similarity NPC189616
0.8056 Intermediate Similarity NPC146731
0.8056 Intermediate Similarity NPC239162
0.8056 Intermediate Similarity NPC296950
0.8051 Intermediate Similarity NPC172154
0.8051 Intermediate Similarity NPC8369
0.8051 Intermediate Similarity NPC81736
0.8039 Intermediate Similarity NPC233345
0.8039 Intermediate Similarity NPC186363
0.8039 Intermediate Similarity NPC473944
0.8037 Intermediate Similarity NPC155332
0.8037 Intermediate Similarity NPC136289
0.8037 Intermediate Similarity NPC114540
0.8037 Intermediate Similarity NPC165250
0.8037 Intermediate Similarity NPC32577
0.8037 Intermediate Similarity NPC235369
0.8037 Intermediate Similarity NPC295791
0.8037 Intermediate Similarity NPC478156
0.8037 Intermediate Similarity NPC80781
0.8034 Intermediate Similarity NPC170538
0.802 Intermediate Similarity NPC168131
0.8019 Intermediate Similarity NPC475385
0.8019 Intermediate Similarity NPC474718
0.8019 Intermediate Similarity NPC471041
0.8019 Intermediate Similarity NPC35751
0.8019 Intermediate Similarity NPC475392
0.8019 Intermediate Similarity NPC472972
0.8019 Intermediate Similarity NPC475202
0.8019 Intermediate Similarity NPC476274
0.8018 Intermediate Similarity NPC286880
0.8018 Intermediate Similarity NPC470496
0.8018 Intermediate Similarity NPC179642
0.8017 Intermediate Similarity NPC184555
0.8 Intermediate Similarity NPC473483
0.8 Intermediate Similarity NPC287668
0.8 Intermediate Similarity NPC285513
0.8 Intermediate Similarity NPC254496
0.8 Intermediate Similarity NPC91695
0.8 Intermediate Similarity NPC37628
0.8 Intermediate Similarity NPC73911
0.8 Intermediate Similarity NPC70145
0.7983 Intermediate Similarity NPC293112
0.7982 Intermediate Similarity NPC111952
0.7982 Intermediate Similarity NPC123726
0.7982 Intermediate Similarity NPC284365
0.7982 Intermediate Similarity NPC102352
0.7982 Intermediate Similarity NPC196931
0.7982 Intermediate Similarity NPC252296
0.7982 Intermediate Similarity NPC34768
0.7981 Intermediate Similarity NPC471786
0.7981 Intermediate Similarity NPC209355
0.7981 Intermediate Similarity NPC274417
0.7981 Intermediate Similarity NPC37603
0.7966 Intermediate Similarity NPC204812
0.7966 Intermediate Similarity NPC120724
0.7965 Intermediate Similarity NPC478212
0.7965 Intermediate Similarity NPC321496
0.7965 Intermediate Similarity NPC122056
0.7963 Intermediate Similarity NPC476848
0.7963 Intermediate Similarity NPC275583
0.7963 Intermediate Similarity NPC36688
0.7963 Intermediate Similarity NPC476889
0.7963 Intermediate Similarity NPC176883
0.7961 Intermediate Similarity NPC475657
0.7961 Intermediate Similarity NPC115021
0.7961 Intermediate Similarity NPC139692
0.7949 Intermediate Similarity NPC67569

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC476802 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7961 Intermediate Similarity NPD5779 Approved
0.7961 Intermediate Similarity NPD5778 Approved
0.7925 Intermediate Similarity NPD7638 Approved
0.785 Intermediate Similarity NPD7640 Approved
0.785 Intermediate Similarity NPD7639 Approved
0.7759 Intermediate Similarity NPD7115 Discovery
0.7757 Intermediate Similarity NPD4225 Approved
0.7692 Intermediate Similarity NPD6411 Approved
0.75 Intermediate Similarity NPD7902 Approved
0.75 Intermediate Similarity NPD6101 Approved
0.75 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.7478 Intermediate Similarity NPD6650 Approved
0.7478 Intermediate Similarity NPD6649 Approved
0.7451 Intermediate Similarity NPD1694 Approved
0.7407 Intermediate Similarity NPD4697 Phase 3
0.7383 Intermediate Similarity NPD7748 Approved
0.7368 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD6899 Approved
0.7368 Intermediate Similarity NPD6881 Approved
0.736 Intermediate Similarity NPD7319 Approved
0.7358 Intermediate Similarity NPD6079 Approved
0.7358 Intermediate Similarity NPD7515 Phase 2
0.7315 Intermediate Similarity NPD1698 Clinical (unspecified phase)
0.7304 Intermediate Similarity NPD6373 Approved
0.7304 Intermediate Similarity NPD6372 Approved
0.729 Intermediate Similarity NPD6399 Phase 3
0.7281 Intermediate Similarity NPD5697 Approved
0.7273 Intermediate Similarity NPD6319 Approved
0.7264 Intermediate Similarity NPD5785 Approved
0.7258 Intermediate Similarity NPD7507 Approved
0.7241 Intermediate Similarity NPD7102 Approved
0.7241 Intermediate Similarity NPD7290 Approved
0.7241 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD6883 Approved
0.7232 Intermediate Similarity NPD7632 Discontinued
0.7222 Intermediate Similarity NPD7900 Approved
0.7222 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7217 Intermediate Similarity NPD6011 Approved
0.7217 Intermediate Similarity NPD6686 Approved
0.7203 Intermediate Similarity NPD4632 Approved
0.7193 Intermediate Similarity NPD6675 Approved
0.7193 Intermediate Similarity NPD6402 Approved
0.7193 Intermediate Similarity NPD6008 Approved
0.7193 Intermediate Similarity NPD5739 Approved
0.7193 Intermediate Similarity NPD7128 Approved
0.7179 Intermediate Similarity NPD6869 Approved
0.7179 Intermediate Similarity NPD6847 Approved
0.7179 Intermediate Similarity NPD8130 Phase 1
0.7179 Intermediate Similarity NPD6617 Approved
0.7177 Intermediate Similarity NPD7492 Approved
0.717 Intermediate Similarity NPD5328 Approved
0.7157 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7155 Intermediate Similarity NPD6012 Approved
0.7155 Intermediate Similarity NPD6013 Approved
0.7155 Intermediate Similarity NPD6014 Approved
0.7155 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD3573 Approved
0.7131 Intermediate Similarity NPD6054 Approved
0.712 Intermediate Similarity NPD6616 Approved
0.7119 Intermediate Similarity NPD6053 Discontinued
0.7119 Intermediate Similarity NPD8297 Approved
0.7119 Intermediate Similarity NPD6882 Approved
0.7097 Intermediate Similarity NPD8328 Phase 3
0.7091 Intermediate Similarity NPD5222 Approved
0.7091 Intermediate Similarity NPD5221 Approved
0.7091 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD8513 Phase 3
0.7073 Intermediate Similarity NPD8516 Approved
0.7073 Intermediate Similarity NPD8515 Approved
0.7073 Intermediate Similarity NPD8517 Approved
0.7069 Intermediate Similarity NPD7320 Approved
0.7063 Intermediate Similarity NPD7078 Approved
0.7048 Intermediate Similarity NPD3618 Phase 1
0.7037 Intermediate Similarity NPD7983 Approved
0.7037 Intermediate Similarity NPD7637 Suspended
0.7027 Intermediate Similarity NPD5173 Approved
0.7025 Intermediate Similarity NPD6009 Approved
0.7016 Intermediate Similarity NPD6370 Approved
0.7008 Intermediate Similarity NPD7736 Approved
0.6991 Remote Similarity NPD5344 Discontinued
0.6983 Remote Similarity NPD5701 Approved
0.6983 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6977 Remote Similarity NPD7260 Phase 2
0.6964 Remote Similarity NPD8029 Clinical (unspecified phase)
0.696 Remote Similarity NPD7604 Phase 2
0.6949 Remote Similarity NPD6371 Approved
0.6949 Remote Similarity NPD4634 Approved
0.6944 Remote Similarity NPD46 Approved
0.6944 Remote Similarity NPD6698 Approved
0.6942 Remote Similarity NPD6868 Approved
0.6935 Remote Similarity NPD6016 Approved
0.6935 Remote Similarity NPD6015 Approved
0.6935 Remote Similarity NPD5983 Phase 2
0.693 Remote Similarity NPD5211 Phase 2
0.6903 Remote Similarity NPD4696 Approved
0.6903 Remote Similarity NPD5285 Approved
0.6903 Remote Similarity NPD6648 Approved
0.6903 Remote Similarity NPD5286 Approved
0.6891 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6887 Remote Similarity NPD5786 Approved
0.6885 Remote Similarity NPD8295 Clinical (unspecified phase)
0.688 Remote Similarity NPD5988 Approved
0.6855 Remote Similarity NPD6059 Approved
0.685 Remote Similarity NPD6336 Discontinued
0.6842 Remote Similarity NPD5223 Approved
0.6829 Remote Similarity NPD6335 Approved
0.681 Remote Similarity NPD5141 Approved
0.6797 Remote Similarity NPD8074 Phase 3
0.6797 Remote Similarity NPD8293 Discontinued
0.6792 Remote Similarity NPD5363 Approved
0.6789 Remote Similarity NPD7838 Discovery
0.6786 Remote Similarity NPD7839 Suspended
0.6783 Remote Similarity NPD5224 Approved
0.6783 Remote Similarity NPD5226 Approved
0.6783 Remote Similarity NPD4633 Approved
0.6783 Remote Similarity NPD5225 Approved
0.6774 Remote Similarity NPD7101 Approved
0.6774 Remote Similarity NPD7100 Approved
0.6748 Remote Similarity NPD6317 Approved
0.6729 Remote Similarity NPD6684 Approved
0.6729 Remote Similarity NPD7334 Approved
0.6729 Remote Similarity NPD6409 Approved
0.6729 Remote Similarity NPD7521 Approved
0.6729 Remote Similarity NPD5330 Approved
0.6729 Remote Similarity NPD7146 Approved
0.6729 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6727 Remote Similarity NPD8034 Phase 2
0.6727 Remote Similarity NPD8035 Phase 2
0.6726 Remote Similarity NPD6084 Phase 2
0.6726 Remote Similarity NPD6083 Phase 2
0.6726 Remote Similarity NPD4755 Approved
0.6724 Remote Similarity NPD5174 Approved
0.6724 Remote Similarity NPD5175 Approved
0.6723 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6698 Remote Similarity NPD4786 Approved
0.6695 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6694 Remote Similarity NPD6313 Approved
0.6694 Remote Similarity NPD6314 Approved
0.6667 Remote Similarity NPD7503 Approved
0.6667 Remote Similarity NPD3667 Approved
0.6667 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6274 Approved
0.6667 Remote Similarity NPD6921 Approved
0.6634 Remote Similarity NPD8039 Approved
0.6609 Remote Similarity NPD4700 Approved
0.6607 Remote Similarity NPD5282 Discontinued
0.6606 Remote Similarity NPD6672 Approved
0.6606 Remote Similarity NPD6903 Approved
0.6606 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6606 Remote Similarity NPD5737 Approved
0.6577 Remote Similarity NPD5281 Approved
0.6577 Remote Similarity NPD5284 Approved
0.6555 Remote Similarity NPD6412 Phase 2
0.6549 Remote Similarity NPD5695 Phase 3
0.6549 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6545 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6542 Remote Similarity NPD3665 Phase 1
0.6542 Remote Similarity NPD3133 Approved
0.6542 Remote Similarity NPD3666 Approved
0.6541 Remote Similarity NPD6845 Suspended
0.6522 Remote Similarity NPD5696 Approved
0.6518 Remote Similarity NPD4202 Approved
0.6509 Remote Similarity NPD5209 Approved
0.6509 Remote Similarity NPD4270 Approved
0.6509 Remote Similarity NPD4269 Approved
0.65 Remote Similarity NPD4730 Approved
0.65 Remote Similarity NPD5168 Approved
0.65 Remote Similarity NPD4729 Approved
0.6489 Remote Similarity NPD6033 Approved
0.6481 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6476 Remote Similarity NPD4695 Discontinued
0.6476 Remote Similarity NPD8259 Clinical (unspecified phase)
0.6441 Remote Similarity NPD4754 Approved
0.6429 Remote Similarity NPD7328 Approved
0.6429 Remote Similarity NPD7327 Approved
0.6429 Remote Similarity NPD5693 Phase 1
0.6423 Remote Similarity NPD6334 Approved
0.6423 Remote Similarity NPD6333 Approved
0.6422 Remote Similarity NPD5279 Phase 3
0.6415 Remote Similarity NPD5369 Approved
0.6406 Remote Similarity NPD6909 Approved
0.6406 Remote Similarity NPD6908 Approved
0.6406 Remote Similarity NPD8033 Approved
0.6404 Remote Similarity NPD5210 Approved
0.6404 Remote Similarity NPD4629 Approved
0.6393 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6393 Remote Similarity NPD5249 Phase 3
0.6393 Remote Similarity NPD5251 Approved
0.6393 Remote Similarity NPD5169 Approved
0.6393 Remote Similarity NPD5248 Approved
0.6393 Remote Similarity NPD5250 Approved
0.6393 Remote Similarity NPD5135 Approved
0.6393 Remote Similarity NPD5247 Approved
0.6389 Remote Similarity NPD6400 Clinical (unspecified phase)
0.6378 Remote Similarity NPD7516 Approved
0.6364 Remote Similarity NPD5128 Approved
0.635 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6341 Remote Similarity NPD5216 Approved
0.6341 Remote Similarity NPD5217 Approved
0.6341 Remote Similarity NPD5127 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data